Milestone Pharmaceuticals Inc.
MIST· Nasdaq
MISTMilestone Pharmaceuticals Inc.
Filed Aug 8, 2024 · 10-Q · 39 days after period end · 0001558370-24-011603
| Metric | Q2 2024 | Q2 2023 | Q2 2022 | Q2 2021 |
|---|---|---|---|---|
| Net Income | -$9.36M | -$16.04M | -$16.65M | $770.00K |
| EPS Diluted | -$0.14 | -$0.37 | -$0.39 | $0.02 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Milestone Pharmaceuticals Inc. · CIK 1408443 · Engraved from SEC EDGAR
ended Jun 30, 2024 · filed Aug 8, 2024 · 39 d after period end
